Shaanxi Meibang Pharmaceutical Group Co., Ltd.

SSE:605033.SS

16.97 (CNY) • At close May 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 00-4.1522.9944.438-12.634-3.424.33569.27633.313-5.225.22391.75262.013-5.71122.86446.57627.438-12.46720.56543.198
Depreciation & Amortization 0005.5245.52419.61-9.2414.9874.9874.2684.2683.6423.64212.478-5.7670.0650.06510.469-5.1680.10.099
Deferred Income Tax 000000000000000000000
Stock Based Compensation 000000000000000000000
Change In Working Capital 000-123.1660183.971-39.14439.144035.088100.41-100.410-399.39486.1-79.803-185.122-98.0224.05-53.964-122.795
Accounts Receivables 000-291.413098.492121.759-121.7590-57.22293.517-293.5170-105.489152.577-152.5770-49.96102.222-66.172-36.05
Change In Inventory 000168.247085.478-160.903160.903092.308-193.107193.1070-293.905-66.47855.59710.881-48.06-78.17336.24541.928
Change In Accounts Payables 000000000000000000000
Other Working Capital 000000000000000-135.4-196.00300-90.208-164.723
Other Non Cash Items 00249.581-120.236-66.08857.153213.351-58.56-4.987-39.356-104.67896.768-91.752-62.0135.7119.99311.981-27.43812.4678.27810.794
Operating Cash Flow 00245.43-122.771-21.65248.1161.546-10.09469.27633.313-5.225.223-0123.493-58.866-46.881-126.5110.3358.27-25.021-68.703
Investing Activities:
Investments In Property Plant And Equipment -53.133-44.333-65.9510.788-49.317-70.941-78.091-30.465-24.194-53.166-43.071-7.22-5.83315.815-64.889-7.63-49.824-3.786-33.364-14.903-9.655
Acquisitions Net 000-00.00600-0.0020.0020.028-000-0.0150.01500-0.0170.0350.0030
Purchases Of Investments -421-931-302-487-578-270-258-255-345-411-24.1-309-189-181-130-305-202-100-140-212
Sales Maturities Of Investments 555.446763.551327431393.244358.979221.68266.147365.709331.59173.847391.069208.70533.05713.02620.08285.745202.604100.487140.552225.377
Other Investing Activites 0.1820.3671.2120.490.4210.4810.2470.3790.8890.6880.5661.49619.705-35.1290.5940.17836.062.8920.1310.0170.136
Investing Cash Flow 81.496-211.414-39.739-55.633-233.64618.52-114.164-18.941-2.594-131.867.24276.34513.871-167.271-64.25412.628-33.019-0.307-32.711-14.3313.858
Financing Activities:
Debt Repayment 0007200-1.0702.07-67.051000-152.669126.98842.717100-10-20-10
Common Stock Issued 000000-25.56737.811025.56700000000000
Common Stock Repurchased 00000-25.91425.567-25.5670-25.56700000000000
Dividends Paid 0-8.0250-20.205-0.009-0.284-0.01-29.7440-0.263-0.435-25.818-0.152-1.235-1.621-0.324-0.112-0.194-0.327-0.204-0.362
Other Financing Activities -29.921-20.044-0.64114.319-12.542-21.6410.462-20.92212.51229.46819.14788.072-0.15262.057340.222-9.888-0-2510-3.638-0.362
Financing Cash Flow -29.921-28.069-0.64166.114-12.551-21.357-0.973-50.66614.582-38.82518.4362.384-0.152-158.904467.2132.3939.888-24.807-0.327-24.204-10.362
Other Information:
Effect Of Forex Changes On Cash 0000000.233-2.06-132.213118.11591.933-55.203-81.7690.0870.01-0.050.012-0.0110.001-0-0
Net Change In Cash -58.321-57.13205.051-126.609-267.847245.26346.642-81.761-50.949-19.257112.405108.749-68.049-202.595344.099-1.91-149.61985.20525.232-63.556-75.207
Cash At End Of Period 161.893220.215304.94999.258184.584452.431207.168160.526242.286293.235312.492200.08791.338159.388361.98317.88419.794169.41284.20858.975122.531